Ahmad Sajjadi, MD, PhD, a UCI Neurologist and UCI MIND faculty member was interviewed live on NBC Los Angeles about the recent announcement that talk show host Wendy Williams…
더 읽어보기
Biogen, the maker of aducanumab has announced that it will terminate the Phase 4 trial required by the FDA for aducanumab, the monoclonal antibody against beta amyloid that received accelerated…
더 읽어보기
The medications have not been widely tested in Black people with the disease, underscoring stark — and persistent — disparities ABINGTON, Pa. — Wrapped in a purple blanket, Robert Williford…
더 읽어보기
In the first study of its kind in humans, researchers have discovered that it is safe to use sound waves fired into specific areas of the brain to open a…
더 읽어보기
TAMPA (BLOOM) – Join us as we explore strategies—from mindful living to emerging technologies—and discover how every choice can lead to a longer and healthier life. Welcome to the science of…
더 읽어보기
Dr. Joshua Grill, Director of UCI MIND is named one of Orange County’s 125 most influential people for 2023 by the Orange County Register! Read article here The post UCI…
더 읽어보기
UCI MIND faculty members, Drs. Mark Mapstone and Mark Fisher were recently quoted in a recent Rolling Stone article on the political divide between younger voters and aging legislators. Check…
더 읽어보기
Some people in their 80s and 90s show shockingly little decline in their brainpower. Scientists are beginning to understand what makes them different and how the rest of us might…
더 읽어보기
More than 6 million Americans have Alzheimer’s disease, and the CDC expects that number to double in the next three decades. The first drug fully approved by the FDA for…
더 읽어보기
On Friday October 13, 2023, the Centers for Medicare and Medicaid Services (CMS) announced a formal change to their coverage policy for amyloid PET imaging. Previously, with limited exceptions, patients were…
더 읽어보기